LyondellBasell Industries (LYB) reported widening losses, with annual losses increasing by 24.8% per year over the past five years. Available forecasts expect revenue to decline 7.1% each year for the next three years, even as analysts see…
Category: 6. Business
-
Bullish Oakley Capital Investments Insiders Loaded Up On UK£1.68m Of Stock
Quite a few insiders have dramatically grown their holdings in Oakley Capital Investments Limited (LON:OCI) over the past 12 months. An insider’s optimism about the company’s prospects is a positive sign.
While we would never suggest that…
Continue Reading
-
Examining Valuation as Market Sentiment Shifts
Eisai (TSE:4523) shares have caught some attention recently. Investors seem to be parsing how shifts in the broader pharmaceutical space, as well as Eisai’s own financial performance, might affect the company’s value in the months ahead.
…
Continue Reading
-
Weight loss jab warning: fraudsters’ fake products ‘could cause real harm’ | Scams
You have heard and read so much about people using weight loss injections to get slim, you feel it is time to give it a go in the run-up to the festive season. The problem is cost.
But it seems there are other options rather than getting a…
Continue Reading
-
Victims robbed of £4bn in ‘insulting’ car loan redress scheme, say claims firms | Motor finance
Victims of the car loans scandal could miss out on more than £4bn in compensation if the City regulator ploughs ahead with plans for an “insulting” interest rate in its redress scheme, consumer groups and claims firms say.
The Financial…
Continue Reading
-
Five-Year Loss Reduction Rate Reinforces Bullish Value Narrative
Adventure (TSE:6030) continues to operate at a loss but has managed to narrow its losses at a steady 5.1% annual rate over the past five years. The stock trades at ¥2,610, just under its estimated fair value of ¥2,624.71, and its…
Continue Reading
-
Aker BioMarine (OB:AKBM) Losses Deepen 15% Annually, Narrative Shifts to Profitability Prospects
Aker BioMarine (OB:AKBM) remains unprofitable, with losses deepening at an average of 15% per year over the past five years. The latest report highlights no turnaround in net profit margin or high-quality earnings. However, the company’s…
Continue Reading
-
How New Developments Are Shaping Analyst Views on Adaptive Biotechnologies’ Future
Adaptive Biotechnologies has seen its fair value estimate climb from $16.00 to $17.14 per share, reflecting a moderate revision upward by market analysts. This change comes as experts weigh Adaptive’s strong standing in cancer diagnostics…
Continue Reading
-
Six new prime property hotspots – including Paris, Madrid and Dubai
Stay informed with free updates
Simply sign up to the Property myFT Digest — delivered directly to your inbox.
Holiday home matchmaking
Hoping to reinvent the way we view holiday homes, a new breed of co-ownership companies now offers the benefits…
Continue Reading
-
The new hot job in AI: forward-deployed engineers
Stay informed with free updates
Simply sign up to the Artificial intelligence myFT Digest — delivered directly to your inbox.
Artificial intelligence groups are on a hiring spree for a rare kind of software developer who can code and talk to…
Continue Reading